| PACKAGING TYPE: | 10x14 Alu-alu (10 Strips In 1 Box) |
| COMPOSITION: | Sacubitril(24mg) & Valsartan(26mg) Tablet |
| FORMULATION: | Tablet |
| Description: | VIOTAN-50 Tablet is a combination of Sacubitril 24 mg and Valsartan 26 mg. It is used for the treatment of chronic heart failure with reduced ejection fraction (HFrEF). Sacubitril enhances natriuretic peptides leading to vasodilation and fluid reduction, while Valsartan blocks angiotensin II receptors, reducing blood pressure and cardiac workload. This dual-action therapy improves heart function and reduces hospitalization risk. |
| Side Effects: | Common: Low blood pressure (hypotension) Dizziness Increased potassium levels Kidney function changes Serious (Rare): Angioedema Severe hypotension Renal impairment Allergic reactions |
| How to Use: | Take as prescribed by a healthcare professional Usually taken twice daily Swallow the tablet with water Can be taken with or without food |
| Precaution: | Monitor blood pressure, kidney function, and potassium levels Avoid concomitant use with ACE inhibitors (washout period required) Use with caution in patients with kidney or liver disorders Inform your doctor about all medications being taken Not recommended during pregnancy |
| Product Benefits: | Improves heart function in heart failure patients Reduces risk of hospitalization and cardiovascular death Promotes vasodilation and reduces fluid overload Enhances quality of life in chronic heart failure Dual-action mechanism for superior efficacy |
Frequently Asked Questions
It is used for chronic heart failure with reduced ejection fraction (HFrEF).
Sacubitril enhances beneficial peptides, while Valsartan reduces harmful effects of angiotensin II, improving heart function.
Yes, under medical supervision with regular monitoring of kidney function and electrolytes.













